The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China in 2019 and is the causal […]
SARS-CoV-2 introduction events in Québec, Canada
Coronavirus disease 2019 (COVID-19) pandemic spread rapidly across the globe, causing over five million deaths and forcing many countries to […]
BNT162b2 mRNA COVID-19 vaccine effectiveness amongst Italian healthcare workers
The ongoing coronavirus disease 2019 (COVID-19) pandemic has been caused by the rapid outbreak of the severe acute respiratory coronavirus […]
Compared to influenza, COVID-19 is more likely to cause venous thrombosis
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been linked to coagulation disturbances, garnering interest in using antithrombotic therapy to […]
Factors impacting mental health and wellbeing of long covid patients
As the coronavirus disease 2019 (COVID-19) pandemic progressed across the world, leaving hundreds of millions of infections in its wake, […]
A mucoadhesive polymer with anti-SARS-COV-2 activity in vitro and in vivo
Researchers have demonstrated the anti-severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) activity of a mucoadhesive polymer that may be used as […]
The effect of a SARS-CoV-2 delta variant mutation associated with higher viral loads
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an RNA virus first reported in 2019 in Wuhan, China. This virus is […]
COVID-19 vaccine effectiveness in New York state
A new preprint available on the preprint server medRxiv* assessed vaccine effectiveness in 8.8 million people in New York six […]
After 5 months, Pfizer-BioNTech COVID vaccine remains highly protective against hospitalization and death
In the face of new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants such as Delta, reasonable concerns have been […]
Moderna vaccine reduced viral load and protected against SARS-CoV-2 variants in new phase 3 trial
Coronavirus research has shown that higher viral loads are associated with severe COVID-19 infection. But new results from the phase […]